μ-Calpain activation, DNA fragmentation, and synergistic effects of caspase and calpain inhibitors in protecting hippocampal neurons from ischemic damage

Brain Research

Volumn 866, Issue 1-2, 2000, Pages 299-312

  Rami, Abdelhaq ^a   Agarwal, Rachna ^a   Botez, Giovannina ^a   Winckler, Jürgen ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Apoptosis; Calpain; Cerebral ischemia; Fodrin; Hippocampus

Indexed keywords

CALPAIN; CALPASTATIN; CASPASE; DNA FRAGMENT; FODRIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN INJURY; BRAIN ISCHEMIA; CELL DIFFERENTIATION; CHROMATIN CONDENSATION; CONTROLLED STUDY; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

AMINO ACID CHLOROMETHYL KETONES; ANIMALS; APOPTOSIS; BENZENESULFONATES; BRAIN ISCHEMIA; CALPAIN; CASPASES; COLORING AGENTS; CYSTEINE PROTEINASE INHIBITORS; DISEASE MODELS, ANIMAL; DNA FRAGMENTATION; DRUG COMBINATIONS; DRUG SYNERGISM; GLYCOPROTEINS; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; MALE; NEURONS; NEUROPROTECTIVE AGENTS; OXAZINES; RATS; RATS, WISTAR; REPERFUSION INJURY;

EID: 0034595540     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(00)02301-5     Document Type: Article

References (52)

1. R.T. Bartus, N.J. Hayward, P.J. Elliot, S.D. Sawyer, K.L. Baker, R.L. Dean et al., Calpain inhibitor AK295 protects neurons from focal brain ischemia: effects of post-occlusion intra-arterial administration, Stroke 25 (1994) 2265-2270.
2. R.T. Bhat, R. DiRocco, V.R. Marcy, D.G. Flood, Y. Zhu, P. Dobrzanski et al., Increased expression of IL-1β converting enzyme in hippocampus after ischemia: selective localisation in microglia, J. Neurosci. 16 (1996) 4146-4154.
3. K. Blomgren, U. Hallin, A.L. Andersson, M. Puka-Sundvall, B.A. Bahr, A. McRae et al., Calpastatin is up-regulated in response to hypoxia and is a suicide substrate to calpain after neonatal cerebral hypoxia-ischemia, J. Biol. Chem. 274 (1999) 14046-14052.
4. L.H. Boise, C.B. Thompson, Bcl-x(L) can inhibit apoptosis in cells that have undergone Fas-induced protease activation, Proc. Natl. Acad. Sci. USA 94 (1997) 3759-3764.
5. N. Canu, L. Dus, C. Barbato, M.T. Ciotti, C. Brancolini, A.M. Rinaldi et al., Tau cleavage and dephosphorylation in cerebellar granule neurons undergoing apoptosis, J. Neurosci. 18 (1998) 7061-7074.
6. E.H. Cheng, D.G. Kirsch, R.J. Clem, R. Ravi, M.B. Kastan, A. Bedi et al., Conversion of bcl-2 to a bax-like death effector by caspases, Science 278 (1997) 1966-1968.
7. J.J. Cohen, Apoptosis, Immunol. Today 14 (1993) 126-130.
8. A. Dosemeci, T.S. Reese, Effect of calpain on the composition and structure of post-synaptic densities, Synapse 20 (1995) 91-97.
9. Y. Egushi, S. Shimizu, Y. Tsujimoto Y, Intracellular ATP levels determine cell death fate by apoptosis or necrosis, Cancer Res. 57 (1997) 1835-1840.
10. M. Enari, H. Sakahira, H. Yokoyama, K. Okawa, A. Iwamatsu, S. Nagata, A caspase-activated DNAse that degrades DNA during apoptosis, and its inhibitor ICAD, Nature 391 (1998) 43-50.
11. M. Enders, Z.Q. Wang, S. Namura, C. Waeber, M. Moskowitz, Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase, J. Cereb. Blood Flow Metab. 17 (1997) 1143-1151.
12. M. Enders, S. Namura, M. Shimizu-Sasamata, C. Waeber, L. Zhang, T. Gomez-Isla et al., Attenuation of delayed neuronal death after mild focal ischemia in mice by inhibition of the caspase family, J. Cereb. Blood Flow Metab. 18 (1998) 238-247.
13. R.M. Friedlander, V. Gagliardini, H. Hara, K.B. Fink, W. Li, G. MacDonald et al., Expression of a dominant negative mutant of ICE in transgenic mice prevents neuronal cell death induced by trophic factor withdrawal and ischemic brain injury, J. Exp. Med. 185 (1997) 933-940.
14. R.M. Friedlander, J. Yuan, ICE, neuronal apoptosis and neurodegeneration, Cell Death Different. 5 (1998) 823-831.
15. Y. Furuya, P. Lundomo, A.D. Short, D.L. Gill, J.T. Isaacs, The role of calcium, pH, and cell proliferation in the programmed (apoptotic) death of androgen-independent prostatic cancer cells induced by thapsigargin, Cancer Res. 54 (1994) 6167-6175.
16. Y. Gavrieli, Y. Sherman, S.A. Ben-Sasson, Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation, J. Cell. Biol. 119 (1992) 493-501.
17. Q. Guo, S. Christakos, N. Robinson, M.P. Mattson, Calbindin-D28k blocks the proapoptotic actions of mutant presenilin 1: reduced oxidative stress and preserved mitochondrial function, Proc. Natl. Acad. Sci. USA 95 (1998) 3221-3232.
18. K. Imaizumi, T. Morihara, Y. Mori, M. Tsuda, T. Furuyama, A. Wanaka et al., The cell death-promoting gene DP5, which interacts with the BCL2 family, is induced during neuronal apoptosis following exposure to amyloid beta protein, J. Biol. Chem. 274 (1999) 7975-7981.
19. M.A. Jianya, M. Enders, M.A. Moskowitz, Synergistic effects of caspase inhibitors and MK-801 in brain injury after transient focal cerebral ischemia in mice, Br. J. Pharmacol. 124 (1998) 756-762.
20. J. Jordan, M.F. Galindo, R. Miller, Role of calpain- and interleukin-1β-converting enzyme-like proteases in the β-amyloid-induced death of rat hippocampal neurons in culture, J. Neurochem. 68 (1997) 1612-1621.
21. S. Kaufmann, S. Desnoyers, Y. Ottaviano, N. Davidson, G. Poirier, Specific proteolytic cleavage of poly(ADP)-ribose) polymerase: an early marker of chemotherapy induced apoptosis, Cancer Res. 53 (1993) 3976-3985.
22. M. Krajewska, H.G. Wang, S. Krajewski, J.M. Zapata, A. Shabaik, R. Gascoyne et al., Immunohistochemical analysis of in vivo patterns of expression of CPP32 (caspase-3), a cell death protease, Cancer Res. 57 (1997) 1605-1613.
23. M.H. Kubbutat, K.H. Vousden, Proteolytic cleavage of human p53 by calpain: a potential regulator of protein stability, Mol. Cell. Biol. 17 (1997) 460-468.
24. K. Kuida, T.S. Zheng, S.Q. Na, D. Kuan, H. Karasuyama, P. Rakic et al., Decreased apoptosis in the brain and premature lethality in CPP32 deficient mice, Nature 384 (1996) 368-372.
25. M. Leist, C. Volbracht, S. Kühnle, E. Fava, E. Ferrando-May, P. Nicotera, Caspase-mediated apoptosis in neuronal excitotoxicity triggered by nitric oxide, Mol. Med. 3 (1997) 750-764.
26. M. Leist, P. Nicotera, Apoptosis, excitotoxicity and neuropathology, Exp. Cell. Res. 239 (1998) 183-201.
27. C.G. Markgraf, N.L. Velayo, M.P. Johnson, D.R. McCarty, S. Mehdi, J.R. Koehl et al., Six-hour window of opportunity for calpain inhibition in focal cerebral ischemia in rats, Stroke 29 (1998) 152-158.
28. R.L. Mellgren, Evidence for participation of a calpain-like cysteine protease in cell cycle progression through late G1 phase, Biochem. Biophy. Res. Commun. 236 (1997) 555-558.
29. E. Melloni, S. Pontremolli, The calpain calpastatin system: structural and functional properties, J. Nutr. Biochem. 2 (1991) 467-476.
30. P. Nicotera, M. Leist, L. Manzo, Neuronal cell death: a demise with different shapes, Trends Pharmacol. Sci. 20 (1999) 46-51.
31. S. Rabizadeh, D.J. LaCount, P.D. Friesen, D.E. Bredesen, Expression of the baculovirus p53 gene inhibits mammalian neural cell death, J. Neurochem. 61 (1993) 2318-2321.
32. A. Rami, J. Krieglstein, Protective effects of calpain inhibitors against neuronal damage caused by cytotoxic hypoxia in vitro and ischemia in vivo, Brain Res. 609 (1993) 67-70.
33. A. Rami, J. Krieglstein, Inhibition of proteolysis prevents neuronal damage caused by cytotoxic hypoxia or ischemia, in: J. Oberpichler, H. Krieglstein (Eds.), Pharmacology of Cerebral Ischemia, Wiss Verlagsges, Stuttgart, 1993, pp. 301-307.
34. A. Rami, J. Krieglstein, Inhibition of proteolysis protects neurons against damage caused hypoxia or ischemia, J. Cereb. Blood Flow Metab. 3 (Suppl. 1) (1993) S646.
35. A. Rami, D. Ferger, J. Kreiglstein J, Blockade of proteolytic activity rescues neurons from glutamate excitotoxicity, Neurosci. Res. 27 (1997) 93-97.
36. R. Sadoul, A.L. Quiquerez, I. Martinou, P.A. Fernandez, J.C. Martinou, p53 expression induces apoptosis in hippocampal pyramidal neuron cultures, Embo. J. 15 (1996) 3845-3852.
37. T.C. Saido, M. Yokota, S. Nagao, I. Yamaura, E. Tani, T. Tsuchiya et al., Spatial resolution of fodrin proteolysis in post-ischemic brain, J. Biol. Chem. 25 (1993) 25239-25243.
38. T.C. Saido, H. Sorimachi, K. Suzuki, Calpain: new perspectives in molecular diversity and physiological-pathological involvement, FASEB J. 8 (1994) 814-822.
39. T.C. Saldo, S. Kwashima, E. Tani, M. Yokta, Up- and down-regulation of calpain inhibitor polypeptide, calpastatin, in post-ischemic hippocampus, Neurosci. Lett. 227 (1997) 756-778.
40. K.I. Saito, J.S. Elce, J.E. Hamos, R.A. Nixon, Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer disease: A potential molecular basis for neuronal degeneration, Proc. Natl. Acad. Sci. USA 90 (1993) 2628-2632.
41. G.P. Schielke, G.Y Yang, B.D. Shivers, A.L. Betz, Reduced ischemic brain injury in interleukin-1β converting enzyme-deficient mice, J. Cereb. Blood Flow Metab. 18 (1998) 180-185.
42. J. Schulz, M. Weller, R.T. Matthews, M.T. Heneka, P. Griscurth, J.C. Martinou et al., Extended therapeutic window for caspase inhibition and synergy with MK-801 in the treatment of cerebral histotoxic hypoxia, Cell Death Different. 5 (1998) 847-857.
43. M.L. Smith, G. Bendek, N. Dahgren, I. Rosén, T. Wieloch, B.K. Siesjö, Models for studying long-term recovery following forebrain ischemia in the rat. A 2-vessel occlusion model, Acta Neurol. Scand. 69 (1984) 385-401.
44. H. Sorimashi, S. Ishiura, K. Suzuki, Structure and physiological function of calpains, Biochem. J. 328 (1997) 721-732.
45. H. Steller, Mechanisms and genes of cellular suicide, Science 267 (1995) 1445.
46. K.T.M. Squier, A.C.K. Miller, A.M. Malkinson, J.J. Cohen, Calpain activation in apoptosis, J. Cell. Physiol. 159 (1994) 229-237.
47. K. Suzuki, H. Sorimashi, T. Yoshizawa, K. Kinbara, S. Ishiura, Calpain: novel family members, activation, and physiologic function, Biol. Chem. 376 (1995) 523-529.
48. A. Takahashi, W. Earnshaw, ICE-related proteases in apoptosis, Curr. Opin. Genet. Dev. 6 (1996) 50-55.
49. D.M. Vanags, M.I. PormAres, S. Coppola, D.H. Burgess, S. Orrenius, Protease involvement in fodrin cleavage and phosphatidylserine exposure in apoptosis, J. Biol. Chem. 271 (1996) 31075-31085.
50. K.K.W. Wang, R. Posmantur, R. Nadimpalli, R. Nath, P. Mohan, R. Nixon et al., Casapse-mediated fragmentation of calpain inhibitor protein calpastatin during apoptosis, Arch. Biochem. Biophys. 356 (1998) 187-196.
51. + efflux and neuronal apoptosis, Science 284 (1999) 336-339.
52. J. Xiang, D.T. Chao, S.J. Korsmeyer, BAX-induced cell death may not require interleukin 1β-converting enzyme-like proteases, Proc. Natl. Acad. Sci. USA 93 (1996) 14559-14563.